Association Between Medication Adherence and the Outcomes of Heart Failure

Sarah R. Hood, Anthony J. Giazzon, Gwen Seamon, Kathleen A. Lane, Jane Wang, George J. Eckert, Wanzhu Tu, Michael Murray

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Previous studies of heart failure patients demonstrated an association between cardiovascular medication adherence and hospitalizations or a composite end point of hospitalization and death. Few studies have assessed the impact of treatment adherence within large general medical populations that distinguish the health outcomes of emergency department visits, hospitalization, and death. Objective: To determine the association of incremental cardiovascular medication adherence on emergency department visits, hospitalization, and death in adult heart failure patients in Indiana. Design: Retrospective cohort study conducted using electronic health record data from the statewide Indiana Network for Patient Care between 2004 and 2009. Methods: Patients were at least 18 years of age with a diagnosis of heart failure and prescribed at least one cardiovascular medication for heart failure. Adherence was measured as the proportion of days covered (PDC) using pharmacy transaction data. Clinical end points included emergency department visits, hospital admissions, length of hospital stay, and mortality. Generalized linear models were used to determine the effect of a 10% increase in PDC on clinical end points adjusting for age, sex, race, Charlson Comorbidity Index, and medications. Results: Electronic health records were available for 55,312 patients (mean age ± standard deviation 68 ± 16 yrs; 54% women; 65% white). Mean PDC for all heart failure medications was 63% ± 23%. For every 10% increase in PDC, emergency department visits decreased 11% (rate ratio [RR] 0.89, 95% confidence interval [CI] 0.89–0.89), hospital admissions decreased 6% (RR 0.94, 95% CI 0.94–0.94), total length of hospital stay decreased 1% (RR 0.99, 95% CI 0.99–1.00), and all-cause mortality decreased 9% (odds ratio 0.91; 95% CI 0.90–0.92). Conclusion: Incremental medication adherence was associated with reductions in emergency department visits, hospital admissions, length of hospital stay, and all-cause mortality.

Original languageEnglish (US)
Pages (from-to)539-545
Number of pages7
JournalPharmacotherapy
Volume38
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Medication Adherence
Length of Stay
Heart Failure
Hospital Emergency Service
Hospitalization
Confidence Intervals
Electronic Health Records
Mortality
Hospital Mortality
Comorbidity
Linear Models
Patient Care
Cohort Studies
Retrospective Studies
Odds Ratio
Health
Population

Keywords

  • electronic medical records
  • health information exchange
  • health outcomes
  • heart failure
  • medication adherence
  • mortality

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Hood, S. R., Giazzon, A. J., Seamon, G., Lane, K. A., Wang, J., Eckert, G. J., ... Murray, M. (2018). Association Between Medication Adherence and the Outcomes of Heart Failure. Pharmacotherapy, 38(5), 539-545. https://doi.org/10.1002/phar.2107

Association Between Medication Adherence and the Outcomes of Heart Failure. / Hood, Sarah R.; Giazzon, Anthony J.; Seamon, Gwen; Lane, Kathleen A.; Wang, Jane; Eckert, George J.; Tu, Wanzhu; Murray, Michael.

In: Pharmacotherapy, Vol. 38, No. 5, 01.05.2018, p. 539-545.

Research output: Contribution to journalArticle

Hood, SR, Giazzon, AJ, Seamon, G, Lane, KA, Wang, J, Eckert, GJ, Tu, W & Murray, M 2018, 'Association Between Medication Adherence and the Outcomes of Heart Failure', Pharmacotherapy, vol. 38, no. 5, pp. 539-545. https://doi.org/10.1002/phar.2107
Hood SR, Giazzon AJ, Seamon G, Lane KA, Wang J, Eckert GJ et al. Association Between Medication Adherence and the Outcomes of Heart Failure. Pharmacotherapy. 2018 May 1;38(5):539-545. https://doi.org/10.1002/phar.2107
Hood, Sarah R. ; Giazzon, Anthony J. ; Seamon, Gwen ; Lane, Kathleen A. ; Wang, Jane ; Eckert, George J. ; Tu, Wanzhu ; Murray, Michael. / Association Between Medication Adherence and the Outcomes of Heart Failure. In: Pharmacotherapy. 2018 ; Vol. 38, No. 5. pp. 539-545.
@article{cf2d18c11ed3437aa68e66f58d961502,
title = "Association Between Medication Adherence and the Outcomes of Heart Failure",
abstract = "Background: Previous studies of heart failure patients demonstrated an association between cardiovascular medication adherence and hospitalizations or a composite end point of hospitalization and death. Few studies have assessed the impact of treatment adherence within large general medical populations that distinguish the health outcomes of emergency department visits, hospitalization, and death. Objective: To determine the association of incremental cardiovascular medication adherence on emergency department visits, hospitalization, and death in adult heart failure patients in Indiana. Design: Retrospective cohort study conducted using electronic health record data from the statewide Indiana Network for Patient Care between 2004 and 2009. Methods: Patients were at least 18 years of age with a diagnosis of heart failure and prescribed at least one cardiovascular medication for heart failure. Adherence was measured as the proportion of days covered (PDC) using pharmacy transaction data. Clinical end points included emergency department visits, hospital admissions, length of hospital stay, and mortality. Generalized linear models were used to determine the effect of a 10{\%} increase in PDC on clinical end points adjusting for age, sex, race, Charlson Comorbidity Index, and medications. Results: Electronic health records were available for 55,312 patients (mean age ± standard deviation 68 ± 16 yrs; 54{\%} women; 65{\%} white). Mean PDC for all heart failure medications was 63{\%} ± 23{\%}. For every 10{\%} increase in PDC, emergency department visits decreased 11{\%} (rate ratio [RR] 0.89, 95{\%} confidence interval [CI] 0.89–0.89), hospital admissions decreased 6{\%} (RR 0.94, 95{\%} CI 0.94–0.94), total length of hospital stay decreased 1{\%} (RR 0.99, 95{\%} CI 0.99–1.00), and all-cause mortality decreased 9{\%} (odds ratio 0.91; 95{\%} CI 0.90–0.92). Conclusion: Incremental medication adherence was associated with reductions in emergency department visits, hospital admissions, length of hospital stay, and all-cause mortality.",
keywords = "electronic medical records, health information exchange, health outcomes, heart failure, medication adherence, mortality",
author = "Hood, {Sarah R.} and Giazzon, {Anthony J.} and Gwen Seamon and Lane, {Kathleen A.} and Jane Wang and Eckert, {George J.} and Wanzhu Tu and Michael Murray",
year = "2018",
month = "5",
day = "1",
doi = "10.1002/phar.2107",
language = "English (US)",
volume = "38",
pages = "539--545",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Association Between Medication Adherence and the Outcomes of Heart Failure

AU - Hood, Sarah R.

AU - Giazzon, Anthony J.

AU - Seamon, Gwen

AU - Lane, Kathleen A.

AU - Wang, Jane

AU - Eckert, George J.

AU - Tu, Wanzhu

AU - Murray, Michael

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Background: Previous studies of heart failure patients demonstrated an association between cardiovascular medication adherence and hospitalizations or a composite end point of hospitalization and death. Few studies have assessed the impact of treatment adherence within large general medical populations that distinguish the health outcomes of emergency department visits, hospitalization, and death. Objective: To determine the association of incremental cardiovascular medication adherence on emergency department visits, hospitalization, and death in adult heart failure patients in Indiana. Design: Retrospective cohort study conducted using electronic health record data from the statewide Indiana Network for Patient Care between 2004 and 2009. Methods: Patients were at least 18 years of age with a diagnosis of heart failure and prescribed at least one cardiovascular medication for heart failure. Adherence was measured as the proportion of days covered (PDC) using pharmacy transaction data. Clinical end points included emergency department visits, hospital admissions, length of hospital stay, and mortality. Generalized linear models were used to determine the effect of a 10% increase in PDC on clinical end points adjusting for age, sex, race, Charlson Comorbidity Index, and medications. Results: Electronic health records were available for 55,312 patients (mean age ± standard deviation 68 ± 16 yrs; 54% women; 65% white). Mean PDC for all heart failure medications was 63% ± 23%. For every 10% increase in PDC, emergency department visits decreased 11% (rate ratio [RR] 0.89, 95% confidence interval [CI] 0.89–0.89), hospital admissions decreased 6% (RR 0.94, 95% CI 0.94–0.94), total length of hospital stay decreased 1% (RR 0.99, 95% CI 0.99–1.00), and all-cause mortality decreased 9% (odds ratio 0.91; 95% CI 0.90–0.92). Conclusion: Incremental medication adherence was associated with reductions in emergency department visits, hospital admissions, length of hospital stay, and all-cause mortality.

AB - Background: Previous studies of heart failure patients demonstrated an association between cardiovascular medication adherence and hospitalizations or a composite end point of hospitalization and death. Few studies have assessed the impact of treatment adherence within large general medical populations that distinguish the health outcomes of emergency department visits, hospitalization, and death. Objective: To determine the association of incremental cardiovascular medication adherence on emergency department visits, hospitalization, and death in adult heart failure patients in Indiana. Design: Retrospective cohort study conducted using electronic health record data from the statewide Indiana Network for Patient Care between 2004 and 2009. Methods: Patients were at least 18 years of age with a diagnosis of heart failure and prescribed at least one cardiovascular medication for heart failure. Adherence was measured as the proportion of days covered (PDC) using pharmacy transaction data. Clinical end points included emergency department visits, hospital admissions, length of hospital stay, and mortality. Generalized linear models were used to determine the effect of a 10% increase in PDC on clinical end points adjusting for age, sex, race, Charlson Comorbidity Index, and medications. Results: Electronic health records were available for 55,312 patients (mean age ± standard deviation 68 ± 16 yrs; 54% women; 65% white). Mean PDC for all heart failure medications was 63% ± 23%. For every 10% increase in PDC, emergency department visits decreased 11% (rate ratio [RR] 0.89, 95% confidence interval [CI] 0.89–0.89), hospital admissions decreased 6% (RR 0.94, 95% CI 0.94–0.94), total length of hospital stay decreased 1% (RR 0.99, 95% CI 0.99–1.00), and all-cause mortality decreased 9% (odds ratio 0.91; 95% CI 0.90–0.92). Conclusion: Incremental medication adherence was associated with reductions in emergency department visits, hospital admissions, length of hospital stay, and all-cause mortality.

KW - electronic medical records

KW - health information exchange

KW - health outcomes

KW - heart failure

KW - medication adherence

KW - mortality

UR - http://www.scopus.com/inward/record.url?scp=85048563701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048563701&partnerID=8YFLogxK

U2 - 10.1002/phar.2107

DO - 10.1002/phar.2107

M3 - Article

C2 - 29600819

AN - SCOPUS:85048563701

VL - 38

SP - 539

EP - 545

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 5

ER -